Dual antiplatelet treatment after stenting: is longer better?

被引:6
|
作者
Sibbing, Dirk [1 ]
Massberg, Steffen
机构
[1] Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 1, D-81377 Munich, Germany
关键词
DRUG-ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; CONTROLLED-TRIAL; DOUBLE-BLIND; THERAPY; IMPLANTATION; DURATION; MULTICENTER; THROMBOSIS; RATIONALE;
D O I
10.1016/S0140-6736(14)60768-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1553 / 1555
页数:3
相关论文
共 50 条
  • [21] Dual Antiplatelet Therapy Duration Following Coronary Stenting
    Yeh, Robert W.
    Mauri, Laura
    Kereiakes, Dean J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (08) : 787 - 790
  • [22] Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome
    Paravattil, Bridget
    Elewa, Hazem
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 22 (04) : 347 - 355
  • [23] Reduced antiplatelet therapy after drug-eluting stenting: Multicenter janus flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 monthsumatrix study
    Cassese, Salvatore
    De Luca, Giuseppe
    Villari, Bruno
    Berti, Sergio
    Bellone, Pietro
    Alfieri, Alfonso
    Montinaro, Antonio
    Quaranta, Gaetano
    Marraccini, Paolo
    Piscione, Federico
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 80 (03) : 408 - 416
  • [24] The Tradeoff Between Shorter and Longer Courses of Dual Antiplatelet Therapy After Implantation of Newer Generation Drug-Eluting Stents
    Bittl, John A.
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (01) : 1 - 6
  • [25] Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?
    Chang M.
    Park D.-W.
    Cardiology and Therapy, 2014, 3 (1-2) : 1 - 12
  • [26] Shorter (≤6 Months) Versus Longer (≥12 Months) Duration Dual Antiplatelet Therapy After Drug Eluting Stents: A Meta-Analysis of Randomized Clinical Trials
    Pandit, Anil
    Giri, Smith
    Hakim, Fayaz Ahmad
    Fortuin, F. David
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 85 (01) : 34 - 40
  • [27] Immunochemical Fecal Occult Blood Tests Predict Dual Antiplatelet Therapy Discontinuation after Coronary Stenting
    Ikeda, Ken
    Koyama, Takashi
    Ishida, Masaru
    Okawa, Megumi
    Oguma, Yasunori
    Terata, Yutaka
    Iino, Kenji
    Kosaka, Toshimitsu
    Watanabe, Hiroyuki
    Ito, Hiroshi
    INTERNAL MEDICINE, 2014, 53 (05) : 375 - 381
  • [28] Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting
    Palmerini, Tullio
    Reggiani, Letizia Bacchi
    Della Riva, Diego
    Romanello, Mattia
    Feres, Fausto
    Abizaid, Alexandre
    Gilard, Martine
    Morice, Marie-Claude
    Valgimigli, Marco
    Hong, Myeong-Ki
    Kim, Byeong-Keuk
    Jang, Yangsoo
    Kim, Hyo-Soo
    Park, Kyung Woo
    Colombo, Antonio
    Chieffo, Alaide
    Ahn, Jung-Min
    Park, Seung-Jung
    Schuepke, Stefanie
    Kastrati, Adnan
    Montalescot, Gilles
    Steg, Philippe Gabriel
    Diallo, Abdourahmane
    Vicaut, Eric
    Helft, Gerard
    Biondi-Zoccai, Giuseppe
    Xu, Bo
    Han, Yaling
    Genereux, Philippe
    Bhatt, Deepak L.
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : 2011 - 2022
  • [29] Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting A Randomized Multicenter Trial
    Valgimigli, Marco
    Campo, Gianluca
    Monti, Monia
    Vranckx, Pascal
    Percoco, Gianfranco
    Tumscitz, Carlo
    Castriota, Fausto
    Colombo, Federico
    Tebaldi, Matteo
    Fuca, Giuseppe
    Kubbajeh, Moh'd
    Cangiano, Elisa
    Minarelli, Monica
    Scalone, Antonella
    Cavazza, Caterina
    Frangione, Alice
    Borghesi, Marco
    Marchesini, Jlenia
    Parrinello, Giovanni
    Ferrari, Roberto
    CIRCULATION, 2012, 125 (16) : 2015 - +
  • [30] Very Short Versus Longer Dual Antiplatelet Treatment After Coronary Interventions: A Systematic Review and Meta-analysis
    Tsigkas, Grigorios
    Apostolos, Anastasios
    Trigka, Aikaterini
    Chlorogiannis, Dimitrios
    Katsanos, Konstantinos
    Toutouzas, Konstantinos
    Alexopoulos, Dimitrios
    Brilakis, Emmanouil S.
    Davlouros, Periklis
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (01) : 35 - 46